Editor: Congress has so far failed to pass long-overdue reform of pharmacy benefit managers and this issue is too serious to delay any longer. Diabetics like me face high out-of-pocket prescription ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. If you’re frustrated with your pharmacy benefit manager ...

Gathering meaningful employee feedback has always been a challenge for benefits leaders, as traditional surveys often offer only surface-level insights that don't capture what employees truly want or ...

Bipartisan legislative activity related to pharmacy benefit manager (PBM) oversight is at an all-time high in both the House and Senate. As we noted last week, several bills that address PBM ...

It's not easy being a benefit manager or HR leader today. With so many competing priorities, a multi-generational workforce with individualized needs, and tighter and tighter budgets, benefit leaders ...

New legislation introduced in both the House and Senate would make it illegal for one company to own both a pharmacy-benefit manager and a pharmacy. Pharmacy benefit managers, or PBMs, are companies ...

The price of prescription drugs has brought scrutiny to the entire drug supply chain. Congress and other policymakers continue to seek opportunities to lower costs for patients and the federal ...

Add Yahoo as a preferred source to see more of our stories on Google. (Getty Images) A bill to regulate pharmaceutical industry middlemen known as pharmacy benefit managers has passed both chambers of ...

Historic levels of dysfunction and infighting may be roiling Congress these days, but lawmakers appear primed to act as soon as they can on at least one issue: Cracking down on pharmacy benefit ...

BOSTON — It took a call to the CEO of Massachusetts Blue Cross Blue Shield for Lauren Hunt, a Watertown resident and the daughter of former Gov. Jane Swift, to sidestep the pharmacy benefit manager ...

Deroy Murdock is a Manhattan-based Fox News contributor and a contributing editor with The American Spectator. President Donald Trump is right. Too many pharmaceuticals are too damn high, especially ...